查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1560967

2024-2032 年按產品、來源、應用、最終用戶和地區分類的生物外科市場報告

Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球生物外科IMARC Group規模達139億美元。該市場的推動因素包括越來越多的外科手術、醫療設備的技術進步以及複雜手術中對有效傷口管理不斷成長的需求，這正在提高全球患者的手術效果和恢復時間。

生物外科市場分析：

  • 主要市場驅動力：慢性病盛行率的增加和人口老化是生物外科市場的主要驅動力，因為它們需要先進的外科干預和傷口護理解決方案。此外，生物材料和外科技術的技術進步也透過提高外科手術的有效性和安全性來推動市場成長。
  • 主要市場趨勢：微創外科手術的趨勢不斷成長，這增加了對支持快速恢復和減少術後併發症的生物外科產品的需求。此外，對個人化醫療和標靶治療的日益關注正在影響針對個別患者需求的生物外科產品的開發。
  • 地理趨勢：由於其先進的醫療基礎設施和新技術的高採用率，北美在生物外科市場中佔有重要佔有率。此外，由於醫療保健投資的增加、意識的提高和患者人數的增加，亞太地區的市場正在經歷快速成長。
  • 競爭格局：一些領先的生物外科公司包括 B. Braun Melsungen AG、Baxter International Inc.、Becton Dickinson and Company、CryoLife Inc.、CSL Limited、Hemostasis LLC、Integra Lifesciences Holdings Corporation、Johnson & Johnson、Medtronic plc、Pfizer Inc .、賽諾菲SA、Smith & Nephew plc、Stryker Corporation 和Surgalign Spine Technologies Inc. 等。
  • 挑戰與機會：生物外科市場的主要挑戰是先進生物外科產品的高成本，這可能限制在成本敏感地區的採用。此外，還有開發具有成本效益的解決方案和擴展到新興市場的重大機會，這些市場不斷提高的醫療保健標準帶來了新的成長潛力。

生物外科市場趨勢：

外科手術數量不斷增加

全球外科手術的持續增加對生物外科市場產生了重大影響。根據美國國立衛生研究院（NIH）統計，2017年對980萬例住院重大手術進行分析發現，11.1%涉及微創手術（MIS），2.5%使用機器人輔助。相較之下，2018 年進行的 960 萬例住院手術中，11.2% 是 MIS，2.9% 是機器人輔助。此外，門診MIS 手術的比例也逐年成長，從2016 年的16.9% 增加到2018 年的18%。安全、更容易。人口老化和對提高生活品質的更加重視導致了這一成長。隨著手術量的增加，對減少併發症和改善療效至關重要的生物外科產品的需求也在增加。密封劑、止血劑和黏合劑等產品擴大用於確保更好的恢復並最大限度地降低術中風險，從而創造了積極的生物外科市場前景。

慢性病增加

心血管疾病、糖尿病和癌症等慢性疾病的盛行率不斷上升，是生物外科市場的另一個關鍵驅動力。美國疾病管制與預防中心指出，60% 的美國成年人患有至少一種慢性疾病，其中許多需要手術介入。據美國慢性病主任協會稱，美國疾病預防控制中心 (CDC) 報告稱，美國每年 3.8 兆美元的醫療保健支出中，90% 與患有慢性病和精神健康問題的個人有關。例如，心臟病和中風是美國的主要原因，每年奪走超過 944,800 人的生命，佔所有死亡人數的三分之一以上。此外，預計到 2050 年，與心血管疾病相關的費用將達到 2 兆美元。隨著慢性病發病率持續增加，對創新生物外科解決方案的需求加劇，鼓勵公司開發和完善滿足複雜醫療需求的技術，從而增加生物外科市場的整體收入。

運動傷害發生率上升

體育參與度和體育活動熱情的增加導致運動相關傷害的發生率更高，這進一步影響了生物外科的市場價值。根據約翰霍普金斯大學醫學報告，美國每年發生超過 350 萬起運動傷害。在體育或娛樂活動造成的所有頭部受傷中，近 50% 是由涉及自行車、滑板或溜冰鞋的事故造成的。此外，每年有超過 775,000 名 15 歲以下兒童到急診室尋求運動相關傷害的照護。這些傷害通常是由於非官方體育賽事或休閒體育賽事期間的跌倒、碰撞和過度勞累造成的。此外，一些運動傷害，包括韌帶撕裂和關節脫位，需要使用生物外科產品的外科手術來促進快速有效的復健。此外，在運動醫學中，這些產品對於加速康復和讓運動員恢復最佳狀態至關重要。隨著業餘和專業水平對運動的興趣持續成長，需要手術干預的損傷的頻率將增加對該領域專門為運動相關治療而設計的生物外科設備的需求。

生物外科市場細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、來源、應用和最終用戶對市場進行了分類。

按產品分類：

  • 骨移植替代品
  • 軟組織附件
  • 止血劑
  • 手術密封劑和黏合劑
  • 黏附屏障
  • 訂書釘線加固

骨移植替代品佔大部分市場佔有率

該報告根據產品提供了詳細的市場細分和分析。這包括骨移植替代品、軟組織附著物、止血劑、手術密封劑和黏合劑、黏連屏障和縫線加固。根據該報告，骨移植替代品佔最大部分。

骨移植替代品是骨移植的重要替代方案。這些替代品在許多外科手術中發揮關鍵作用，支持骨科、創傷、脊椎手術和牙科應用中的骨再生和修復。它們的目的是透過促進骨骼發育和取代傳統的自體移植物來最大程度地降低供體部位發病和感染的風險，傳統的自體移植需要從患者自己的身體中取出骨骼。此外，骨骼和關節問題日益頻繁、對侵入性較小的手術的需求以及生物材料技術的發展也推動了這種擴張。此細分市場的成長也得益於具有改進的骨傳導和骨誘導品質的新型合成和複合移植物的創造。例如，2023 年 5 月 23 日，Royal Biologics, Inc. 是一家專注於先進細胞和自體技術以改善手術結果的公司，推出了 BIO-REIGN 3D。這種創新的骨移植替代品是第一個使用天然超交聯碳水化合物聚合物的產品。它旨在增強骨移植手術，這項專有技術是與 Royal Biologics 就 Molecular Matrix 專利 Osteo-P BGS 技術的授權協議一起推出的。

按來源分類：

  • 天然/生物製品
  • 合成產品

天然/生物製品佔據產業最大佔有率

報告還根據來源提供了詳細的市場細分和分析。這包括天然/生物製品和合成產品。報告稱，天然/生物製品佔據最大的市場佔有率。

根據生物外科市場概況，天然/生物製劑因其有效的治療特性和生物相容性而代表了最大的部分。這些產品源自於人體或其他生物來源中天然存在的物質，包括纖維蛋白密封劑、膠原蛋白基質和殼聚醣溶液。此外，天然/生物製劑產品模仿自然生理過程的能力顯著降低了排斥和不良反應的風險，使其成為外科手術中的首選。此外，生物技術的進步進一步增強了這些材料的安全性和有效性，從而進一步支持了市場主導地位。因此，對微創手術的需求不斷成長，加上需要複雜手術的慢性疾病的盛行率不斷上升，繼續推動市場上天然/生物製品的成長。

按應用分類：

  • 骨科手術
  • 一般外科
  • 神經外科
  • 心血管外科
  • 婦科手術
  • 其他

神經外科代表領先的細分市場

該報告根據應用程式提供了詳細的市場細分和分析。這包括骨科手術、一般外科、神經外科、心血管外科、婦科手術等。根據該報告，神經外科手術佔最大部分。

神經外科手術非常複雜，並且需要嚴格的精確度。此外，生物外科產品，如封閉劑、止血劑和沾黏屏障，廣泛用於神經手術中以控制出血、密封組織並減少術後併發症。此外，腦腫瘤、癲癇和帕金森氏症等神經系統疾病的盛行率不斷上升，加上神經外科技術的進步，使得這一領域的需求不斷增加。此外，微創（MI）手術的廣泛採用需要高效的生物外科解決方案來提高患者的治療效果，這進一步推動了生物外科市場的成長。這一趨勢得到了生物外科產品技術創新的支持，旨在改善手術結果並縮短恢復時間。

按最終用戶分類：

  • 醫院
  • 診所
  • 其他

醫院在市場上表現出明顯的主導地位

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院、診所和其他。報告顯示，醫院佔據了最大的市場。

醫院提供各種經常使用生物外科產品的外科手術。這些產品包括止血劑、手術密封劑和黏合劑，對於控制術中和術後出血以及促進組織癒合至關重要。此外，醫院處理大量患者和進行複雜手術的能力增加了生物外科的需求。此外，手術技術的不斷進步和對微創手術的日益偏好進一步擴大了生物外科解決方案在醫院環境中的使用率。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美市場領先，佔據最大的生物外科市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是生物外科最大的區域市場。

北美因其先進的醫療基礎設施、對研發 (R&D) 活動的大量投資以及推動創新和擴張的領先企業的存在而成為領先地區。此外，北美慢性病盛行率的增加和老年人口的增加導致對生物外科產品的需求增加。根據生物外科市場預測，這些因素加上有利的政府政策和微創手術的強勁趨勢，將繼續加強北美在全球生物外科市場的領先地位。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

  • 目前，生物外科市場參與者正在透過策略合作、創新產品發布和新地域市場擴張等相結合的方式積極促進市場成長。這些公司在研發 (R&D) 方面投入巨資，推出先進產品，滿足微創手術和改善傷口護理日益成長的需求。此外，市場參與者正專注於獲得不同地區的監管批准，這有助於擴大其全球足跡並進入新市場。這些策略共同促進了生物外科市場的強勁成長和彈性。例如，2023 年，AROA Biosurgery Ltd. 發布了一個新的回顧性試驗案例係列，探索使用 Myriad Matrix 和 Myriad Morcells 對受污染的體積軟組織缺損進行手術治療。它在一家機構檢查了 10 名患者的 13 處複雜創傷傷口。研究報告實現軟組織覆蓋和填充的平均時間為 23.4+-9.2 天，平均使用一次產品，參與者沒有出現併發症。此外，研究的重點是美國一級創傷中心的機動車事故損傷、疝氣修復後的腹部裂開、福尼爾壞疽、筋膜室症候群和壓力性損傷。結果發現，Myriad 產品促進了有效的軟組織形成，並且沒有報告併發症，從而增強了 AROA ECM 產品在創傷護理中的實用性。

生物外科市場新聞：

  • 2023 年 11 月，強生醫療科技公司 Ethicon 宣布批准 ETHIZIA，這是一種止血解決方案，可在挑戰性情況下有效、持久地控制嚴重出血。這種新型止血貼片增強了 Ethicon 廣泛的生物外科產品系列，並增強了其滿足出血控制緊急需求的能力。

本報告回答的關鍵問題：

  • 迄今為止，全球生物外科市場表現如何，未來幾年將如何表現？
  • 全球生物外科市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球生物外科市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的生物外科市場？
  • 基於產品的市場區隔是什麼？
  • 生物外科市場上最具吸引力的產品是什麼？
  • 依來源分類市場是怎麼樣的？
  • 哪個是生物外科市場中最具吸引力的來源？
  • 基於應用程式的市場區隔是什麼？
  • 生物外科市場中哪一個應用最有吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 哪個是生物外科市場中最具吸引力的最終用戶？
  • 市場競爭結構如何？
  • 誰是全球生物外科市場的主要參與者/公司？

本報告回答的關鍵問題：

  • 迄今為止，全球生物外科市場表現如何，未來幾年將如何表現？
  • 全球生物外科市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球生物外科市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的生物外科市場？
  • 基於產品的市場區隔是什麼？
  • 生物外科市場上最具吸引力的產品是什麼？
  • 基於來源的市場區隔是什麼？
  • 哪個是生物外科市場中最具吸引力的來源？
  • 基於應用程式的市場區隔是什麼？
  • 生物外科市場中哪一個應用最有吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 哪個是生物外科市場中最具吸引力的最終用戶？
  • 市場競爭結構如何？
  • 全球生物外科市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物外科市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 骨移植替代品
    • 市場趨勢
    • 市場預測
  • 軟組織附件
    • 市場趨勢
    • 市場預測
  • 止血劑
    • 市場趨勢
    • 市場預測
  • 手術密封劑和黏合劑
    • 市場趨勢
    • 市場預測
  • 黏附屏障
    • 市場趨勢
    • 市場預測
  • 訂書釘線加固
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依來源分類

  • 天然/生物製品
    • 市場趨勢
    • 市場預測
  • 合成產品
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 骨科手術
    • 市場趨勢
    • 市場預測
  • 一般外科
    • 市場趨勢
    • 市場預測
  • 神經外科
    • 市場趨勢
    • 市場預測
  • 心血管外科
    • 市場趨勢
    • 市場預測
  • 婦科手術
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • CryoLife Inc.
    • CSL Limited
    • Hemostasis LLC
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Sanofi SA
    • Smith & Nephew plc
    • Stryker Corporation
    • Surgalign Spine Technologies Inc.
Product Code: SR112024A4522

The global biosurgery market size reached US$ 13.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The market is driven by the increasing surgical procedures, technological advancements in medical devices, and growing demand for effective wound management in complex surgeries, which is enhancing surgical outcomes and recovery times for patients across the globe.

Biosurgery Market Analysis:

  • Major Market Drivers: The increasing prevalence of chronic diseases and the aging population are major drivers for the biosurgery market, as they necessitate advanced surgical interventions and wound care solutions. Moreover, technological advancements in biomaterials and surgical techniques are also driving market growth by enhancing the effectiveness and safety of surgical procedures.
  • Key Market Trends: There is a growing trend toward minimally invasive surgical procedures, which is escalating the demand for biosurgical products that support quick recovery and reduced post-operative complications. Besides, increased focus on personalized medicine and targeted therapies are influencing the development of biosurgical products tailored to individual patient needs.
  • Geographical Trends: North America holds a significant share of the biosurgery market due to its advanced healthcare infrastructure and high adoption rates of new technologies. Moreover, the markets in Asia-Pacific are experiencing rapid growth due to rising healthcare investments, increasing awareness, and a growing patient population.
  • Competitive Landscape: Some of the leading biosurgery companies include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc., among many others.
  • Challenges and Opportunities: The major challenge in the biosurgery market is the high cost of advanced biosurgical products, which can limit adoption in cost-sensitive regions. Moreover, there are significant opportunities for developing cost-effective solutions and expanding into emerging markets, where rising healthcare standards present new growth potential.

Biosurgery Market Trends:

The Growing Number of Surgical Procedures

The consistent increase in surgical procedures globally significantly impacts the biosurgery market. As reported by the National Institutes of Health (NIH) statistics, in 2017, an analysis of 9.8 million major inpatient surgical procedures revealed that 11.1% involved minimally invasive surgery (MIS) and 2.5% utilized robotic assistance. This compares to the 9.6 million inpatient surgeries performed in 2018, where 11.2% were MIS and 2.9% were robotic assisted. Additionally, the percentage of ambulatory MIS procedures also grew annually, from 16.9% in 2016 to 18% in 2018.. This uptick is largely driven by advancements in medical technology and surgical techniques, which have made surgeries safer and more accessible. An aging population and a greater focus on enhancing quality of life contribute to this increase. As surgical volumes grow, the demand for biosurgery products, essential for reducing complications and improving outcomes, also increases. Products such as sealants, hemostatic agents, and adhesives are increasingly used to ensure better recovery and minimize intraoperative risks, thereby creating a positive biosurgery market outlook.

Increase in Chronic Diseases

The escalating prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer is another pivotal driver for the biosurgery market. The Centers for Disease Control and Prevention notes that 60% of U.S. adults suffer from at least one chronic disease, many of which necessitate surgical interventions. According to the National Association of Chronic Disease Directors, the CDC reports that 90% of the annual $3.8 Trillion healthcare expenditure in the U.S. is linked to individuals with chronic illnesses and mental health conditions. For instance, heart disease and stroke are the leading causes of death in the United States, claiming over 944,800 lives annually, which accounts for more than one-third of all deaths. Furthermore, it is projected that the costs associated with cardiovascular diseases will reach $2 Trillion by 2050. Additionally, surgical interventions often include the use of biosurgery products to manage blood loss, repair tissues, and promote healing, particularly in complex procedures. As the incidence of chronic diseases continues to increase, the demand for innovative biosurgery solutions intensifies, encouraging companies to develop and refine technologies that cater to complex medical needs, thus increasing the overall biosurgery market revenue.

Rising Incidence of Sports Injuries

The increase in sports participation and enthusiasm for physical activities has led to a higher incidence of sports-related injuries, which is further influencing the biosurgery market value. According to a John Hopkins Medicine report, in the United States (US) over 3.5 million sports injuries occur each year. Almost 50% of all head injuries from sports or recreational activities are the result of incidents involving bicycles, skateboards, or skates. In addition, more than 775,000 kids under the age of 15 seek care for sports-related injuries in emergency departments yearly. These injuries frequently result from falls, collisions, and overexertion during unofficial sporting events or recreational athletic events. Besides, several sports injuries, including ligament rips and joint dislocations, need surgical procedures that use biosurgery products to promote a speedy and efficient recovery. Moreover, in sports medicine, these products are essential for accelerating recovery and getting players back to their best. As interest in sports continues to grow at amateur and professional levels, the frequency of injuries requiring surgical intervention will increase demand for biosurgery devices specifically designed for sports-related treatments in this sector.

Biosurgery Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, source, application and end user.

Breakup by Product:

  • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement

Bone-graft substitutes account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. According to the report, bone-graft substitutes represented the largest segment.

Bone-graft substitutes are crucial alternatives to bone grafting. These stand-ins play a critical role in many surgical operations, supporting bone regeneration and repair in orthopedics, trauma, spine surgery, and dentistry applications. They are intended to minimize the risk of donor site morbidity and infection by promoting bone development and replacing conventional autografts, which require removing bone from the patient's own body. Furthermore, the expansion is driven by the increasing frequency of bone and joint problems, the need for less intrusive operations, and developments in biomaterial technology. The growth of this market segment is also fueled by the creation of novel synthetic and composite grafts with improved osteoconductive and osteoinductive qualities. For instance, on 23 May 2023, Royal Biologics, Inc., a company focused on advanced cellular and autologous technologies for improved surgical outcomes, unveiled BIO-REIGN 3D. This innovative bone graft substitute is the first to use a natural hyper-crosslinked carbohydrate polymer. It is designed to enhance bone grafting procedures, and this proprietary technology is introduced alongside Royal Biologics' licensing agreement for Molecular Matrix's patented Osteo-P BGS technology.

Breakup by Source:

  • Natural/Biologics Products
  • Synthetic Products

Natural/biologics products hold the largest share of the industry

A detailed breakup and analysis of the market based on the source have also been provided in the report. This includes natural/biologics products and synthetic products. According to the report, natural/biologics products accounted for the largest market share.

According to the biosurgery market overview, natural/biologics represent the largest segment due to their effective healing properties and biocompatibility. These products, derived from substances that are naturally present in the human body or other biological sources, include fibrin sealants, collagen-based matrices, and chitosan-based solutions. Additionally, natural/biologics product's ability to mimic natural physiological processes significantly reduces the risk of rejection and adverse reactions, making them highly preferred in surgical procedures. Moreover, market dominance is further supported by advancements in biotechnology that enhance the safety and efficacy of these materials. Consequently, the increasing demand for minimally invasive surgeries, coupled with the growing prevalence of chronic diseases requiring complex surgeries, continues to drive the growth of natural/biologics products in the market.

Breakup by Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Others

Neurological surgery represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, and others. According to the report, neurological surgery represented the largest segment.

Neurological surgeries are complex and require critical precision. Additionally, biosurgery products, such as sealants, hemostatic agents, and adhesion barriers, are extensively used in neurological procedures to manage bleeding, seal tissues, and reduce post-operative complications. Moreover, the rising prevalence of neurological disorders, such as brain tumors, epilepsy, and Parkinson's disease, coupled with advancements in neurosurgical techniques are escalating the demand in this segment. Besides, the widespread adoption of minimally invasive (MI) surgeries, which require highly effective biosurgical solutions to enhance patient outcomes is further driving the biosurgery market growth. This trend is supported by technological innovations in biosurgery products, aimed at improving surgical outcomes and reducing recovery times.

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Hospital exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, and others. According to the report, hospitals accounted for the largest market share.

Hospitals offer a wide array of surgical procedures that frequently utilize biosurgical products. These products, which include hemostatic agents, surgical sealants, and adhesives, are integral in managing intraoperative and postoperative bleeding and promoting tissue healing. Additionally, hospitals' capacity to handle high patient volumes and conduct complex surgeries increases biosurgery demand. Additionally, the constant advancements in surgical techniques and the increasing preference for minimally invasive surgeries further amplify the utilization of biosurgical solutions in hospital settings.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biosurgery market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for biosurgery.

North America is the leading region due to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Additionally, the increasing prevalence of chronic diseases and the growing elderly population in North America contribute to a higher demand for biosurgical products. According to the biosurgery market forecast, these factors, combined with favorable government policies and a strong trend toward minimally invasive surgeries, will continue to strengthen North America's leading position in the global biosurgery market.

Competitive Landscape:

  • The biosurgery market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • At present, biosurgery market players are actively enhancing market growth through a combination of strategic collaborations, innovative product launches, and expansions into new geographical markets. These companies invest heavily in research and development (R&D) to introduce advanced products that meet the increasing demands of minimally invasive surgeries and improved wound care. Additionally, market players are focusing on obtaining regulatory approvals across different regions, which helps in expanding their global footprint and accessing new markets. These strategies collectively contribute to the robust growth and resilience of the biosurgery market. For instance, in 2023, AROA Biosurgery Ltd. revealed the release of a new retrospective pilot case series that explores the use of Myriad Matrix and Myriad Morcells in the surgical treatment of contaminated volumetric soft tissue defects. It reviewed 13 complex traumatic wounds in 10 patients at a single facility. The study reported an average time of 23.4+-9.2 days for achieving soft tissue coverage and fill, with a median of one product application and no complications among participants. Moreover, the research focused on injuries from motor vehicle accidents, abdominal dehiscence after hernia repair, Fournier's Gangrene, compartment syndrome, and pressure injuries at a US Level 1 trauma center. It found that the Myriad products facilitated effective soft tissue formation with no reported complications, reinforcing the utility of AROA ECM products in trauma care.

Biosurgery Market News:

  • November 2023, Ethicon, a Johnson & Johnson MedTech company, has announced the approval of ETHIZIA, a hemostatic solution shown to provide effective and lasting control of severe bleeding in challenging situations. This new hemostatic patch enhances Ethicon's extensive biosurgery range and strengthens its capability to meet urgent needs in bleeding control.

Key Questions Answered in This Report:

  • How has the global biosurgery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biosurgery market?
  • What is the impact of each driver, restraint, and opportunity on the global biosurgery market?
  • What are the key regional markets?
  • Which countries represent the most attractive biosurgery market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biosurgery market?
  • What is the breakup of the market based on the source?
  • Which is the most attractive source in the biosurgery market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biosurgery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biosurgery market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biosurgery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosurgery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone-Graft Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Soft-Tissue Attachments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hemostatic Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Sealants and Adhesives
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Barriers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Staple Line Reinforcement
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Natural/Biologics Products
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 General Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurological Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gynecological Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Baxter International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CryoLife Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 CSL Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Hemostasis LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Integra Lifesciences Holdings Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Smith & Nephew plc
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Stryker Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Surgalign Spine Technologies Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Biosurgery Market: Major Drivers and Challenges
  • Figure 2: Global: Biosurgery Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biosurgery Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biosurgery Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Biosurgery Market: Breakup by Source (in %), 2023
  • Figure 6: Global: Biosurgery Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biosurgery Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biosurgery Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biosurgery (Bone-Graft Substitutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biosurgery (Bone-Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biosurgery (Soft-Tissue Attachments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biosurgery (Soft-Tissue Attachments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biosurgery (Hemostatic Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biosurgery (Hemostatic Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biosurgery (Surgical Sealants and Adhesives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biosurgery (Surgical Sealants and Adhesives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biosurgery (Adhesion Barriers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biosurgery (Adhesion Barriers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biosurgery (Staple Line Reinforcement) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biosurgery (Staple Line Reinforcement) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biosurgery (Natural/Biologics Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biosurgery (Natural/Biologics Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biosurgery (Synthetic Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biosurgery (Synthetic Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biosurgery (Orthopedic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biosurgery (Orthopedic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biosurgery (General Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biosurgery (General Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Biosurgery (Neurological Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Biosurgery (Neurological Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Biosurgery (Cardiovascular Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Biosurgery (Cardiovascular Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Biosurgery (Gynecological Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Biosurgery (Gynecological Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Biosurgery (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Biosurgery (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Biosurgery (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Biosurgery (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Biosurgery (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Biosurgery (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Biosurgery (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Biosurgery (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia-Pacific: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia-Pacific: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Biosurgery Market: Breakup by Country (in %), 2023
  • Figure 91: Middle East and Africa: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Global: Biosurgery Industry: SWOT Analysis
  • Figure 93: Global: Biosurgery Industry: Value Chain Analysis
  • Figure 94: Global: Biosurgery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosurgery Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biosurgery Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Biosurgery Market Forecast: Breakup by Source (in Million US$), 2024-2032
  • Table 4: Global: Biosurgery Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biosurgery Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Biosurgery Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Biosurgery Market: Competitive Structure
  • Table 8: Global: Biosurgery Market: Key Players